The coronary stent market in the Asia-Pacific (APAC) region is witnessing sustained growth, driven by rising coronary artery ...

Nongenetic factors and rare genetic variants were sources of variation that could influence the association between age at menarche and CAD.

A phase 1b showed promising results in lowering LDL in patients with heterozygous familial hypercholesterolemia and/or ...

A new study published in the journal of BMC Cardiovascular Diabetelogy showed that an elevated liver fat fraction (LFF) on ...

St. Luke’s University Health Network now offers a proven, noninvasive diagnostic option for people with suspected heart ...

Among patients with stable coronary artery disease, colchicine lowered total plaque volume compared with placebo but had no ...

CAMBRIDGE, Mass. & ATLANTA & SEOUL, South Korea, April 15, 2025--Cellino Announces Partnership with Karis Bio to Develop First Nebula™-Powered Autologous iPSC Therapy for Cardiovascular Disease ...

Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...

The global absorbable heart stent market, valued at US$ 307.1 million in 2022, is projected to experience substantial growth in the coming years. With a forecasted compound annual growth rate (CAGR) ...

Verve shares Phase 1b results of VERVE-102, showing dose-dependent LDL-C reductions and strong safety in patients with HeFH ...

A recent study reveals that combining a reduced-calorie Mediterranean diet with regular exercise, including walking and ...